Carbamic Acid

Carbamic Acid

SCHEMBL286743

NC(=O)O.NC(O)=S

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Carbamic Acid SCHEMBL28066638 1.00 ACHE (0.70)
Bicarbonate SCHEMBL8726606 0.90
Urea SCHEMBL27396614 0.90 ALDH1A1 (0.60)
Carbamic Acid SCHEMBL11497074 0.90
Urea SCHEMBL5996634 0.90
Carbamic Acid SCHEMBL5903963 0.90
Carbamic Acid SCHEMBL27811102 0.86
Bicarbonate SCHEMBL8142662 0.86 ACHE (0.50)
SCHEMBL2295699 0.84 TSHR (0.62)
SCHEMBL26254 0.84

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2427778-A2 ANALYSIS OF MEMBRANE COMPONENT INTERACTIONS Molecular Sensing, Inc. (US) 2012-03-14 EP claimed
JP-4838934-B2 2011-12-14 JP claimed
EP-1042291-B1 ARYL-SUBSTITUTED PYRIDYLALKANE, ALKENE, AND ALKINE CARBOXAMIDES USEFUL AS CYTOSTATIC AND IMMUNOSUPPRESSIVE AGENTS KLINGE CO CHEM PHARM FAB (DE) 2005-07-13 EP claimed
EP-1042291-A1 ARYL-SUBSTITUTED PYRIDYLALKANE, ALKENE, AND ALKINE CARBOXAMIDES USEFUL AS CYTOSTATIC AND IMMUNOSUPPRESSIVE AGENTS Klinge Pharma GmbH (DE) 2000-10-11 EP claimed
WO-1999031064-A1 ARYL-SUBSTITUTED PYRIDYLALKANE, ALKENE, AND ALKINE CARBOXAMIDES USEFUL AS CYTOSTATIC AND IMMUNOSUPPRESSIVE AGENTS KLINGE PHARMA GMBH (DE) 1999-06-24 WO claimed
CN-116194500-A Composition comprising graphene-based material as lubricant additive 赢创运营有限公司 2023-05-30 CN disclosed
CN-109970760-B ACC inhibitors and uses thereof 吉利德阿波罗公司 2022-04-26 CN disclosed
CN-113228343-A Solid electrolyte composition, solid electrolyte-containing sheet, all-solid-state secondary battery, and method for producing solid electrolyte-containing sheet and all-solid-state secondary battery 富士胶片株式会社 2021-08-06 CN disclosed
EP-3362436-B1 PROCESS FOR THE CATALYTIC DIRECTED CLEAVAGE OF AMIDE-CONTAINING COMPOUNDS UNIV ANTWERPEN (BE) 2021-06-30 EP disclosed
EP-3296309-B1 GALACTOPYRANOSYL DERIVATIVES USEFUL AS MEDICAMENTS UNIV GENT (BE) 2019-08-07 EP disclosed
CN-109970760-A ACC inhibitor and its purposes 吉利德阿波罗公司 2019-07-05 CN disclosed
CN-106905346-B ACC inhibitor and its purposes 吉利德阿波罗公司 2019-05-28 CN disclosed
EP-1042291-B1 ARYL-SUBSTITUTED PYRIDYLALKANE, ALKENE, AND ALKINE CARBOXAMIDES USEFUL AS CYTOSTATIC AND IMMUNOSUPPRESSIVE AGENTS KLINGE CO CHEM PHARM FAB (DE) 2005-07-13 EP disclosed
EP-1317430-A1 (2-AZABICYCLO 2.2.1]HEPT-7-YL)METHANOL DERIVATIVES AS NICOTINIC ACETYLCHOLINE RECEPTOR AGONISTS MERCK PATENT GmbH (DE) 2003-06-11 EP disclosed
CN-1414989-A Method of preparing optical polymerizate PPG IND OHIO INC (US) 2003-04-30 CN disclosed
CN-1414990-A Method of preparing optical polymerizate PPG IND OHIO INC (US) 2003-04-30 CN disclosed
WO-2002022578-A1 (2-AZABICYCLO[2.2.1]HEPT-7-YL)METHANOL DERIVATIVES AS NICOTINIC ACETYLCHOLINE RECEPTOR AGONISTS MERCK PATENT GMBH (DE) 2002-03-21 WO disclosed
EP-1042291-A1 ARYL-SUBSTITUTED PYRIDYLALKANE, ALKENE, AND ALKINE CARBOXAMIDES USEFUL AS CYTOSTATIC AND IMMUNOSUPPRESSIVE AGENTS Klinge Pharma GmbH (DE) 2000-10-11 EP disclosed
WO-1999031064-A1 ARYL-SUBSTITUTED PYRIDYLALKANE, ALKENE, AND ALKINE CARBOXAMIDES USEFUL AS CYTOSTATIC AND IMMUNOSUPPRESSIVE AGENTS KLINGE PHARMA GMBH (DE) 1999-06-24 WO disclosed
EP-0199042-A1 Procainamide assay, tracers, immunogens and antibodies ABBOTT LABORATORIES (US) 1986-10-29 EP disclosed